NCT03332056 The Use of Belladonna and Opium Suppository in the Treatment of Postoperative Stent Pain Status COMPLETED Phase PHASE4
NCT03331341 Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT03323801 RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia Status COMPLETED Phase PHASE2
NCT03316183 Cerebral Monitor Guided Therapy on Cerebral Outcomes After Cardiac Surgery Status NOT_YET_RECRUITING Phase NA
NCT03298373 28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men Status UNKNOWN Phase PHASE1
NCT03297905 Functional Restoration and Integrative Therapies in Service Members With Neuromusculoskeletal Injury Status UNKNOWN Phase NA
NCT03295981 Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone Status RECRUITING Phase PHASE3
NCT03292692 Empirically-Based Couple Interventions on the Web: Serving the Underserved Status COMPLETED Phase NA
NCT03289572 Microgrid II - Electrocorticography Signals for Human Hand Prosthetics Status UNKNOWN Phase N/A
NCT03289377 NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers Status UNKNOWN Phase NA
NCT03283462 Bioenergetics and Muscle Function Improvement With AMAZ-02 in Elderly Skeletal Muscle (ENERGIZE Trial) Status COMPLETED Phase NA
NCT03272828 Mandibular Overdenture Clinical Trial Comparing Parallel Sided and Tapered Dental Implants Status COMPLETED Phase NA
NCT03269552 Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma Status TERMINATED Phase PHASE2
NCT03260504 Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer Status TERMINATED Phase PHASE1
NCT03256110 Palliative Care Communication With Alaska Native and American Indian People Status COMPLETED Phase NA
NCT03256045 Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE2